Mar 24, 2016 21:30 pm UTC| Business
MINNEAPOLIS, March 24, 2016 -- Skyline Medical Inc. (NASDAQ:SKLN) (the “Company”) today announced the commencement of its registered exchange offer (the “Exchange Offer”) to issue new Series B Warrants of the Company in...
SmartFinancial, Inc. (Nasdaq: SMBK) to Ring The Nasdaq Stock Market Closing Bell
Mar 24, 2016 21:21 pm UTC| Business
ADVISORY, March 24, 2016 -- What: SmartFinancial, Inc. (Nasdaq:SMBK), the Knoxville, Tennessee-based bank holding company for SmartBank, will visit the Nasdaq MarketSite in Times Square. In honor of the occasion,...
Lucy Hobbs Project announces 2016 honorees
Mar 24, 2016 21:08 pm UTC| Business
PITTSTON, Pa., March 24, 2016 -- With a network of more than 9,000 members, The Lucy Hobbs Project's commission to select six honorees each year for the distinction of Exemplary Women in the Dental Community is no easy...
EVS Wins in Excess of $400 Thousand Order for IQ-TEX4 Systems for Denim Application
Mar 24, 2016 21:00 pm UTC| Business
CAESAREA, Israel, March 24, 2016 -- Elbit Vision Systems Ltd. (OTC:EVSNF), a pioneer in the science of camera-based automatic vision inspection for textile fabrics and technical webs, announced today that it received an...
American Electric Technologies to Report Fourth Quarter and FY 2015 Results
Mar 24, 2016 21:00 pm UTC| Business
HOUSTON, March 24, 2016 -- American Electric Technologies, Inc. (NASDAQ:AETI), a leading provider of power delivery solutions for the global energy industry, has scheduled its quarterly conference call to discuss fourth...
Quantum Technologies Receives NASDAQ Delisting Notification
Mar 24, 2016 20:56 pm UTC| Business
LAKE FOREST, Calif., March 24, 2016 -- Quantum Fuel Systems Technologies Worldwide, Inc. (“Quantum” or the “Company”) (NASDAQ:QTWW), a leader in natural gas storage and delivery systems, integration and vehicle system...
Axsome Therapeutics Reports Fourth Quarter and Full Year 2015 Financial Results
Mar 24, 2016 20:30 pm UTC| Business
NEW YORK, March 24, 2016 -- Axsome Therapeutics, Inc. (NASDAQ:AXSM), a clinical-stage biopharmaceutical company developing novel therapies for the management of central nervous system (CNS) disorders, today reported...